Terms: = Brain cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Treatment
113 results:
1. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
2. Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk-benefit analysis.
Alhalabi OT; Dao Trong P; Kaes M; Jakobs M; Kessler T; Oehler H; König L; Eichkorn T; Sahm F; Debus J; von Deimling A; Wick W; Wick A; Krieg SM; Unterberg AW; Jungk C
J Neurooncol; 2024 Apr; 167(2):245-255. PubMed ID: 38334907
[TBL] [Abstract] [Full Text] [Related]
3. A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam.
Pham CP; Nguyen TTH; Do AT; Nguyen TK; Hoang TAT; Le TA; Vuong DTH; Nguyen DNT; Dang VK; Nguyen TO; Pham VL; Nguyen MH; Vo THT; Do HK; Vu HT; Nguyen TTH; Pham VT; Trinh LH; Nguyen KD; Nguyen HG; Truong CM; Pham TMC; Nguyen TBP
BMC Cancer; 2024 Feb; 24(1):176. PubMed ID: 38317094
[TBL] [Abstract] [Full Text] [Related]
4. A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.
Li Y; Lv X; Chen C; Yu R; Wang B; Wang D; Hou D
Eur Radiol Exp; 2024 Jan; 8(1):2. PubMed ID: 38169047
[TBL] [Abstract] [Full Text] [Related]
5. Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
Flecchia C; Auclin E; Alouani E; Mercier M; Hollebecque A; Turpin A; Mazard T; Pernot S; Dutherage M; Cohen R; Borg C; Hautefeuille V; Sclafani F; Ben-Abdelghani M; Aparicio T; De La Fouchardière C; Herve C; Perkins G; Heinrich K; Kunzmann V; Gallois C; Guimbaud R; Tougeron D; Taieb J
Br J Cancer; 2024 Feb; 130(3):442-449. PubMed ID: 38102227
[TBL] [Abstract] [Full Text] [Related]
6. Suprasellar masquerader: Chordoid glioma.
Bhardwaj N; Salunke P; Singla N; Ahuja C; Gendle C; Gupta K
Clin Neuropathol; 2024; 43(1):23-28. PubMed ID: 37675487
[TBL] [Abstract] [Full Text] [Related]
7. Automated brain Tumor Detection and Segmentation for treatment Response Assessment Using Amino Acid PET.
Gutsche R; Lowis C; Ziemons K; Kocher M; Ceccon G; Régio Brambilla C; Shah NJ; Langen KJ; Galldiks N; Isensee F; Lohmann P
J Nucl Med; 2023 Oct; 64(10):1594-1602. PubMed ID: 37562802
[TBL] [Abstract] [Full Text] [Related]
8. Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial.
Cappelli L; Khan MM; Kayne A; Poiset S; Miller R; Ali A; Niazi M; Shi W; Alnahhas I
Chin Clin Oncol; 2023 Jun; 12(3):23. PubMed ID: 37417289
[TBL] [Abstract] [Full Text] [Related]
9. [Regional variation in usage of ttf (Optune)].
Kinhult S; Tavelin B; Löfgren D; Rosenlund L; Sandström M; Strandeus M; Henriksson R
Lakartidningen; 2023 Jul; 120():. PubMed ID: 37401252
[TBL] [Abstract] [Full Text] [Related]
10. Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map.
Fu M; Zhou Z; Huang X; Chen Z; Zhang L; Zhang J; Hua W; Mao Y
BMC Cancer; 2023 Jun; 23(1):544. PubMed ID: 37316802
[TBL] [Abstract] [Full Text] [Related]
11. treatment of hydrocephalus following posterior fossa tumor resection: a multicenter collaboration from the Hydrocephalus Clinical Research Network.
Dewan MC; Isaacs AM; Cools MJ; Yengo-Kahn A; Naftel RP; Jensen H; Reeder RW; Holubkov R; Haizel-Cobbina J; Riva-Cambrin J; Jafrani RJ; Pindrik JA; Jackson EM; Judy BF; Kurudza E; Pollack IF; Mcdowell MM; Hankinson TC; Staulcup S; Hauptman J; Hall K; Tamber MS; Cheong A; Warsi NM; Rocque BG; Saccomano BW; Snyder RI; Kulkarni AV; Kestle JRW; Wellons JC;
J Neurooncol; 2023 May; 163(1):123-132. PubMed ID: 37129738
[TBL] [Abstract] [Full Text] [Related]
12. Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study.
Kim H; Ahn BC; Lee J; Lee JB; Hong MH; Kim HR; Cho BC; Lim SM
Lung Cancer; 2023 Jun; 180():107213. PubMed ID: 37104879
[TBL] [Abstract] [Full Text] [Related]
13. Relationship between brain metastasis and thyroid transcription factor 1.
Kut E; Menekşe S
Sci Rep; 2023 Feb; 13(1):1945. PubMed ID: 36732655
[TBL] [Abstract] [Full Text] [Related]
14. Modeling of intracranial tumor treating fields for the treatment of complex high-grade gliomas.
Segar DJ; Bernstock JD; Arnaout O; Bi WL; Friedman GK; Langer R; Traverso G; Rampersad SM
Sci Rep; 2023 Jan; 13(1):1636. PubMed ID: 36717682
[TBL] [Abstract] [Full Text] [Related]
15. Safety and efficacy of tumour-treating fields (ttfields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-ttf System: a prospective post-approval study.
Nishikawa R; Yamasaki F; Arakawa Y; Muragaki Y; Narita Y; Tanaka S; Yamaguchi S; Mukasa A; Kanamori M
Jpn J Clin Oncol; 2023 Apr; 53(5):371-377. PubMed ID: 36647599
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT).
Sheng X; Ye D; Zhou A; Yao X; Luo H; He Z; Wang Z; Zhao Y; Ji Z; Zou Q; He C; Guo J; Tu X; Liu Z; Shi B; Liu B; Chen P; Wei Q; Hu Z; Zhang Y; Jiang K; Zhou F; Wu D; Fu C; Li X; Wu B; Wang L; Qin S; Li G; Liu Y; Guo H; Chen K; Zhang D; Wang G; Ding L; Wang Y; Yuan X; Guo J
Eur J Cancer; 2023 Jan; 178():205-215. PubMed ID: 36459768
[TBL] [Abstract] [Full Text] [Related]
17. TSPO PET signal using [
Quach S; Holzgreve A; Kaiser L; Unterrainer M; Dekorsy FJ; Nelwan DV; Bartos LM; Kirchleitner SV; Weller J; Weidner L; Niyazi M; Ruf VC; Herms J; Stöcklein S; Wetzel C; Riemenschneider MJ; V Baumgarten L; Thon N; Brendel M; Rupprecht R; Bartenstein P; Tonn JC; Albert NL
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):859-869. PubMed ID: 36329288
[TBL] [Abstract] [Full Text] [Related]
18. Current therapeutic options for glioblastoma and future perspectives.
Aquilanti E; Wen PY
Expert Opin Pharmacother; 2022 Oct; 23(14):1629-1640. PubMed ID: 36100970
[TBL] [Abstract] [Full Text] [Related]
19. Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment.
Chen B; Zhou X; Yang L; Zhou H; Meng M; Wu H; Liu Z; Zhang L; Li C
CNS Neurosci Ther; 2022 Dec; 28(12):2148-2162. PubMed ID: 36070228
[TBL] [Abstract] [Full Text] [Related]
20. External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney cancer Consortium (TKCC) Database.
Yekedüz E; Karakaya S; Ertürk İ; Tural D; Uçar G; Şentürk Öztaş N; Arıkan R; Hızal M; Küçükarda A; Sever ÖN; Arslan Ç; Can O; Kılıçkap S; Yazgan C; Karadurmuş N; Şendur MA; Çiçin İ; Demirci U; Özgüroğlu M; Öksüzoğlu B; Ürün Y
Clin Genitourin Cancer; 2023 Feb; 21(1):175-182. PubMed ID: 35970759
[TBL] [Abstract] [Full Text] [Related]
[Next]
